Amedeo Smart

Free Medical Literature Service



Multiple Sclerosis

  Free Subscription


1 J Neuroimmunol
2 J Neurol
2 J Neurol Sci
1 Magn Reson Med
3 Mult Scler
1 PLoS One
1 Rev Neurol
1 Rev Neurol (Paris)

    J Neuroimmunol

  1. CHANG EH, Hardy TA
    Peripheral oedema as an adverse effect of treatment of secondary progressive multiple sclerosis with siponimod: A case series.
    J Neuroimmunol. 2024;389:578330.
    >> Share

    J Neurol

  2. ALBERGONI M, Pagani E, Preziosa P, Meani A, et al
    Thalamic nuclei volume partially mediates the effects of aerobic capacity on fatigue in people with multiple sclerosis.
    J Neurol. 2024 Mar 20. doi: 10.1007/s00415-024-12277.
    >> Share

  3. ABDELGAIED MY, Rashad MH, El-Tayebi HM, Solayman MH, et al
    Correction to: The impact of metformin use on the outcomes of relapse?remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open?label randomized controlled trial.
    J Neurol. 2024 Mar 18. doi: 10.1007/s00415-024-12249.
    >> Share

    J Neurol Sci

  4. CHAER LER, de Mendonca JM, Del Negro MC, Titze-de-Almeida R, et al
    Differential diagnosis between multiple sclerosis and leukodystrophies - A scoping review.
    J Neurol Sci. 2024;459:122969.
    >> Share

  5. BERNARDES C, Fernandes C, Cunha C, Nunes C, et al
    Natalizumab extended interval dosing: what about wearing-off effect?
    J Neurol Sci. 2024;458:122930.
    >> Share

    Magn Reson Med

  6. FUJITA S, Gagoski B, Hwang KP, Hagiwara A, et al
    Cross-vendor multiparametric mapping of the human brain using 3D-QALAS: A multicenter and multivendor study.
    Magn Reson Med. 2024;91:1863-1875.
    >> Share

    Mult Scler

  7. CAMPAGNA MP, Havrdova EK, Horakova D, Izquierdo G, et al
    No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.
    Mult Scler. 2024 Mar 21:13524585241240406. doi: 10.1177/13524585241240406.
    >> Share

  8. HJALGRIM H, Rostgaard K
    Infectious mononucleosis and risk of multiple sclerosis: Proxy or culprit?
    Mult Scler. 2024 Mar 21:13524585241237708. doi: 10.1177/13524585241237708.
    >> Share

    Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023.
    Mult Scler. 2024 Mar 21:13524585241237707. doi: 10.1177/13524585241237707.
    >> Share

    PLoS One

  10. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    >> Share

    Rev Neurol

  11. ROJAS JI, Gracia F, Parciak T, Alonso R, et al
    [Core data set for real world data in multiple sclerosis: customization for latin america from a global task force recommendation].
    Rev Neurol. 2024;78:185-197.
    >> Share

    Rev Neurol (Paris)

  12. MARRIE RA, Maxwell CJ, Rotstein DL, Tsai CC, et al
    Prodromes in demyelinating disorders, amyotrophic lateral sclerosis, Parkinson disease, and Alzheimer's dementia.
    Rev Neurol (Paris). 2023 Aug 9:S0035-3787(23)00983.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016